Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Receivables Refunds: 2009-2022

Historic Receivables Refunds for Avadel Pharmaceuticals (AVDL) over the last 9 years, with Sep 2022 value amounting to $2.1 million.

  • Avadel Pharmaceuticals' Receivables Refunds fell 16.69% to $2.1 million in Q3 2022 from the same period last year, while for Sep 2022 it was $2.1 million, marking a year-over-year decrease of 16.69%. This contributed to the annual value of $2.4 million for FY2021, which is 26.55% down from last year.
  • Avadel Pharmaceuticals' Receivables Refunds amounted to $2.1 million in Q3 2022, which was down 5.80% from $2.2 million recorded in Q2 2022.
  • In the past 5 years, Avadel Pharmaceuticals' Receivables Refunds registered a high of $3.3 million during Q4 2020, and its lowest value of $283,000 during Q4 2018.
  • Over the past 3 years, Avadel Pharmaceuticals' median Receivables Refunds value was $2.5 million (recorded in 2021), while the average stood at $2.5 million.
  • In the last 5 years, Avadel Pharmaceuticals' Receivables Refunds soared by 644.52% in 2019 and then fell by 26.55% in 2021.
  • Avadel Pharmaceuticals' Receivables Refunds (Quarterly) stood at $283,000 in 2018, then soared by 644.52% to $2.1 million in 2019, then skyrocketed by 57.85% to $3.3 million in 2020, then dropped by 26.55% to $2.4 million in 2021, then declined by 16.69% to $2.1 million in 2022.
  • Its last three reported values are $2.1 million in Q3 2022, $2.2 million for Q2 2022, and $2.4 million during Q1 2022.